Texas Round-Up: Lone Star State Ropes in Over $1.1 Billion in Capital Projects from Pharmaceutical-Biotech Sector
Texas Round-Up: Lone Star State Ropes in Over $1.1 Billion in Capital Projects from Pharmaceutical-Biotech Sector
Attachment: Texas Future Pharma-Biotech Industry Spending Analysis Chart
Underscoring the truth to the old adage - Everything is bigger in Texas - the projects carry an impressive average total investment value (TIV) of $51 million...
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects